Assessment of myocardial viability with gated SPECT Tc-99m sestamibi imaging during administration of sublingual nitroglycerin

MLA

Mark I. Travin, et al. “Assessment of Myocardial Viability with Gated SPECT Tc-99m Sestamibi Imaging during Administration of Sublingual Nitroglycerin.” Journal of Nuclear Cardiology, vol. 2, Mar. 1995, p. S97. EBSCOhost, https://doi.org/10.1016/s1071-3581(05)80471-4.

APA

Mark I. Travin, Steven D. Herman, David G. Wolinsky, John Miskewicz, & Gary V. Heller. (1995). Assessment of myocardial viability with gated SPECT Tc-99m sestamibi imaging during administration of sublingual nitroglycerin. Journal of Nuclear Cardiology, 2, S97. https://doi.org/10.1016/s1071-3581(05)80471-4

Chicago

Mark I. Travin, Steven D. Herman, David G. Wolinsky, John Miskewicz, and Gary V. Heller. 1995. “Assessment of Myocardial Viability with Gated SPECT Tc-99m Sestamibi Imaging during Administration of Sublingual Nitroglycerin.” Journal of Nuclear Cardiology 2 (March): S97. doi:10.1016/s1071-3581(05)80471-4.